WCLC 2022 Conference Coverage
Playback speed
10 seconds
WCLC 2022 on the Phase 3 SANOVO Study: Savolitinib or Placebo in Combination With Osimertinib in EGFRm and MET Overexpressed NSCLC
By
WCLC 2022 Conference Coverage
FEATURING
Qing Zhou
By
WCLC 2022 Conference Coverage
FEATURING
Qing Zhou
0 views
August 18, 2022
Comments 0
Login to view comments.
Click here to Login
Videos